Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3907 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Scientists make HIV T-cells breakthrough

The researchers found that HIV can simply ‘turn off’ fully functional T-cells by flipping a molecular switch on the cells. In test tube studies, however, the scientists showed

Barr initiates Pliva tender offer

Barr is battling Iceland’s Actavis for control of the Croatian generic drug maker. However, Barr remains the favorite to complete the $2.3 billion deal with its 755 Kuna

Merck to launch third HIV expanded access program

Expanded access is a mechanism supported by regulatory agencies for getting investigational treatment to patients who have a life-threatening disease and who cannot be satisfactorily treated with an

BMS and Otsuka launch new oral Abilify formulation

Abilify Discmelt (aripiprazole) provides a convenient alternative for adults with schizophrenia or manic episodes associated with bipolar I disorder. Pharmacokinetic studies showed that Abilify Discmelt orally disintegrating tablets